Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study (Q39332971)

11 September 2017

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study (English)

1 reference

11 September 2017

0 references

1 reference

Rainer Freynhagen

2

0 references

author name string

Thomas Tölle

1

1 reference

11 September 2017

Mark Versavel

3

1 reference

11 September 2017

Uwe Trostmann

4

1 reference

11 September 2017

James P Young

5

1 reference

11 September 2017

16 July 2007

1 reference

11 September 2017

European Journal of Pain

1 reference

11 September 2017

12

1 reference

11 September 2017

2

1 reference

11 September 2017

203-213

1 reference

The management of persistent pain in older persons

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Diabetic peripheral neuropathy and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Unmet Needs in the Management of Neuropathic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Understanding the impact of painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2007.05.003

10.1016/J.EJPAIN.2007.05.003

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference